ArticleHealthcare (Basel, Switzerland)2026
Safety of Initiating Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure or Type 2 Diabetes and a History of Urinary Tract Infections.
Jacqueline Rever et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.